Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Menstrual Migraine: later-stage trial registry
1 of 4 indexed Menstrual Migraine trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Menstrual Migraine: 4 US clinical trials tracked, 1 recruiting.
Menstrual Migraine is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Cady, Roger, M.D., running 1 of these trials.
Enrollment posture brief
Registry condition menstrual-migraine
OPEN 1 | RECR 25% | LATE 4 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Menstrual Migraine lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Menstrual Migraine on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Menstrual Migraine is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Pfizer
NCT06641466
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
Brigham and Women's Hospital
NCT06173661
CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
Cady, Roger, M.D.
NCT01329562
An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine
University of Alabama at Birmingham
NCT01578941
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Menstrual Migraine records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Menstrual Migraine trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Menstrual Migraine page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Menstrual Migraine trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cady, Roger, M.D. sponsors the most Menstrual Migraine trials on record, review their full trial history before evaluating a specific study. See Cady, Roger, M.D.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Menstrual Migraine condition card totals 4 registered trials; most-linked intervention Treximet; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.